Eurofins Scientific SE
ERFSF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $12,940,418 | $9,655,915 | $10,033,579 | $11,295,620 |
| - Cash | $753,300 | $613,900 | $681,200 | $1,221,200 |
| + Debt | $4,113,700 | $3,610,300 | $3,544,100 | $3,926,500 |
| Enterprise Value | $16,300,818 | $12,652,315 | $12,896,479 | $14,000,920 |
| Revenue | $3,612,000 | $3,532,300 | $3,418,700 | $3,305,100 |
| % Growth | 2.3% | 3.3% | 3.4% | – |
| Gross Profit | $810,200 | $3,955,600 | $756,600 | $1,107,800 |
| % Margin | 22.4% | 112% | 22.1% | 33.5% |
| EBITDA | $817,500 | $613,700 | $753,200 | $554,300 |
| % Margin | 22.6% | 17.4% | 22% | 16.8% |
| Net Income | $246,600 | $185,700 | $220,700 | $158,800 |
| % Margin | 6.8% | 5.3% | 6.5% | 4.8% |
| EPS Diluted | 1.16 | 0.83 | 1 | 0.67 |
| % Growth | 39.8% | -17% | 49.3% | – |
| Operating Cash Flow | $526,300 | $788,600 | $530,300 | $627,400 |
| Capital Expenditures | -$221,300 | -$310,900 | -$217,500 | -$287,400 |
| Free Cash Flow | $305,000 | $477,700 | $312,800 | $340,000 |